scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Duong TA | |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | emerging pathogen | Q108429945 |
Talaromyces marneffei | Q2317277 | ||
P304 | page(s) | 125-130 | |
P577 | publication date | 1996-07-01 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases | |
P478 | volume | 23 |
Q43820687 | A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand |
Q39613966 | A rare skin presentation of Penicillium marneffei infection in an AIDS patient |
Q35019850 | AIDS-associated Penicillium marneffei infection of the central nervous system |
Q52604571 | Accuracy of rapid diagnosis of Talaromyces marneffei: A systematic review and meta-analysis. |
Q40183430 | Acute Abdomen Due to Penicillium marneffei: An Indicator of HIV Infection in Manipur State |
Q40363459 | Administration of Voriconazole in Disseminated Talaromyces (Penicillium) Marneffei Infection: A Retrospective Study |
Q34162712 | An overview of fungal infections |
Q40878512 | Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches |
Q90401387 | Application of Flow Cytometry in the Diagnostics Pipeline of Primary Immunodeficiencies Underlying Disseminated Talaromyces marneffei Infection in HIV-Negative Children |
Q39575552 | Approach to Fungal Infections in Human Immunodeficiency Virus-Infected Individuals: Pneumocystis and Beyond |
Q39464125 | Biotyping of Penicillium marneffei reveals concentration-dependent growth inhibition by galactose |
Q35804495 | Bloodstream Infections among HIV-Infected Outpatients, Southeast Asia |
Q98163382 | Burden of Talaromyces marneffei infection in people living with HIV/AIDS in Asia during ART era: a systematic review and meta-analysis |
Q92025941 | Central Nervous System Infection with Other Endemic Mycoses: Rare Manifestation of Blastomycosis, Paracoccidioidomycosis, Talaromycosis, and Sporotrichosis |
Q40047750 | Clinical Characteristics and Prognosis of Penicilliosis Among Human Immunodeficiency Virus-Infected Patients in Eastern China. |
Q35008241 | Clinical and laboratory characteristics of penicilliosis marneffei among patients with and without HIV infection in Northern Thailand: a retrospective study |
Q33826134 | Clinical presentation and significance of emerging opportunistic infections |
Q34784730 | Clinical profile of HIV/AIDS-infected patients admitted to a new specialist unit in Dhaka, Bangladesh--a low-prevalence country for HIV |
Q30583695 | Clinical, morphological, and molecular characterization of Penicillium canis sp. nov., isolated from a dog with osteomyelitis. |
Q37992671 | Common skin conditions in children with HIV/AIDS. |
Q38497233 | Comprehensive transcription analysis of human pathogenic fungus Penicillium marneffei in mycelial and yeast cells |
Q57610549 | Cytological Diagnosis of Penicillium marneffei Infection |
Q39467744 | Detection of cell wall mannoprotein Mp1p in culture supernatants of Penicillium marneffei and in sera of penicilliosis patients |
Q39555177 | Detection of specific antibodies to an antigenic mannoprotein for diagnosis of Penicillium marneffei penicilliosis |
Q54237827 | Development and characterization of an immunochromatographic test for the rapid diagnosis of Talaromyces (Penicillium) marneffei. |
Q38970862 | Development and evaluation of rapid urinary antigen detection tests for diagnosis of penicilliosis marneffei |
Q54495111 | Development of TaqMan real-time polymerase chain reaction for the detection and identification of Penicillium marneffei. |
Q24554498 | Diagnosis of Penicillium marneffei infection by quantitation of urinary antigen by using an enzyme immunoassay |
Q33974371 | Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients. |
Q34526781 | Differential cytokine pattern in the spleens and livers of BALB/c mice infected with Penicillium marneffei: protective role of gamma interferon. |
Q33909786 | Disseminated Penicillium marneffei infection in an African AIDS patient |
Q37582315 | Disseminated Penicillium marneffei infection recurrence in a non-acquired immune deficiency syndrome patient: A case report |
Q35038469 | Emerging and less common fungal pathogens |
Q37045251 | Emerging diseases in tropical dermatology |
Q34373864 | Emerging fungal infections among children: A review on its clinical manifestations, diagnosis, and prevention |
Q33672774 | Endoscopic diagnosis of intestinal penicilliosis marneffei: report of three cases and review of the literature. |
Q37464169 | Environmental predictors and incubation period of AIDS-associated penicillium marneffei infection in Ho Chi Minh City, Vietnam |
Q35019780 | Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam. |
Q36103156 | Evaluation and management of fungal infections in immunocompromised patients |
Q35718206 | Evaluation of the matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Bruker Biotyper for identification of Penicillium marneffei, Paecilomyces species, Fusarium solani, Rhizopus species, and Pseudallescheria boydii |
Q49936105 | Fatal Talaromyces marneffei Infection in a Patient with Autoimmune Hepatitis |
Q31145758 | First observation in a non-endemic country (Togo) of Penicillium marneffei infection in a human immunodeficiency virus-infected patient: a case report |
Q34415324 | Fungal infection of the colon |
Q51700759 | Fungal infections among returning travelers. |
Q34775235 | Fungal infections associated with HIV infection |
Q36768045 | Fungal infections of the CNS: treatment strategies for the immunocompromised patient |
Q33961800 | Fungal resistance |
Q34056471 | HIV disease: mucocutaneous fungal infections in HIV disease |
Q33868769 | Histopathologic diagnosis of fungal infections in the 21st century |
Q35622011 | Human hyalohyphomycoses: a review of human infections due to Acremonium spp., Paecilomyces spp., Penicillium spp., and Scopulariopsis spp. |
Q33661366 | Identification and purification of specific Penicillium marneffei antigens and their recognition by human immune sera |
Q43642103 | Identification of Penicillium marneffei in Paraffin-Embedded Tissue Using Nested PCR. |
Q34113622 | Immunoassays based on Penicillium marneffei Mp1p derived from Pichia pastoris expression system for diagnosis of penicilliosis |
Q38111802 | Immunodetection of fungal and oomycete pathogens: established and emerging threats to human health, animal welfare and global food security |
Q36546164 | Immunoreactivity of a 38-kilodalton Penicillium marneffei antigen with human immunodeficiency virus-positive sera |
Q33962157 | Indigenous disseminated Penicillium marneffei infection in the state of Manipur, India: report of four autochthonous cases |
Q96137876 | Localized Talaromyces marneffei infection presenting as a tonsillar mass mimicking malignancy |
Q33751318 | MP1 encodes an abundant and highly antigenic cell wall mannoprotein in the pathogenic fungus Penicillium marneffei. |
Q51675349 | Macrophage colony-stimulating factor enhances phagocytosis and oxidative burst of mononuclear phagocytes againstPenicillium marneffeiconidia |
Q35585991 | Massive hepatosplenomegaly caused by Penicillium marneffei associated with human immunodeficiency virus infection in a Thai patient. |
Q35583347 | Mixed bloodstream infection with Staphylococcus aureus and Penicillium chrysogenum in an immunocompromised patient: case report and review of the literature |
Q51585101 | Molecular identification of Penicillium marneffei using rolling circle amplification. |
Q35826749 | More Than Just Oligomannose: An N-glycomic Comparison of Penicillium Species |
Q44252751 | Mucocutaneous manifestations of HIV infection in 91 children born to HIV-seropositive women |
Q40503731 | Multiple brain abscesses due to Penicillium spp infection |
Q35116244 | Newer antifungal therapy for emerging fungal pathogens |
Q38363105 | Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies |
Q38807260 | Organism-wide studies into pathogenicity and morphogenesis in Talaromyces marneffei |
Q42545545 | Penicillinosis in a HIV-positive individual |
Q40346922 | Penicilliosis in Vietnam: a series of 94 patients |
Q34572362 | Penicillium marneffei Infection in AIDS. |
Q39654078 | Penicillium marneffei causes osteopontin-mediated production of interleukin-12 by peripheral blood mononuclear cells |
Q24537359 | Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects |
Q38391154 | Penicillium marneffei infection in a lung transplant recipient |
Q35959714 | Penicillium marneffei infection presenting as vulv-ulcer in an HIV-infected woman |
Q40274215 | Penicillium marneffei infection: an emerging disease in mainland China |
Q34775285 | Prevalence and classification of HIV-associated oral lesions. |
Q37306096 | Respiratory infections unique to Asia |
Q35066373 | Retrospective analysis of 14 cases of disseminated Penicillium marneffei infection with osteolytic lesions |
Q40283097 | Role of Cannomys badius as a natural animal host of Penicillium marneffei in India |
Q37189919 | Role of laccase in the virulence of Talaromyces marneffei: A common link between AIDS-related fungal pathogens? |
Q57602329 | Supercritical Carbon Dioxide as Non-Thermal Alternative Technology for Safe Handling of Clinical Wastes |
Q26767153 | Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients |
Q37189950 | Talaromyces marneffei laccase modifies THP-1 macrophage responses |
Q91866310 | Talaromycosis-Associated Secondary Hemophagocytic Lymphohistiocytosis in Nine Human Immunodeficiency Virus-Negative Patients: A Multicenter Retrospective Study |
Q34579146 | The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century |
Q27485255 | Transmission of Tropical and Geographically Restricted Infections during Solid-Organ Transplantation |
Q37970481 | Travel-related disseminated Penicillium marneffei infection in a renal transplant patient |
Q37264077 | Unraveling the molecular basis of temperature-dependent genetic regulation in Penicillium marneffei |
Q34541319 | Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens |
Q34802129 | Voriconazole-Resistant Penicillium oxalicum: An Emerging Pathogen in Immunocompromised Hosts |
Q73542756 | [Disseminated Penicillium marneffei infection in a HIV-infected patient] |
Q52952140 | [Risk of immunosuppression. Systemic mycoses]. |
Search more.